Selby_Lancet_CGH_Nov04_CMYK.pdf (133.8 kB)
The Lancet Gastroenterology & Hepatology Journal Cover November 1st 2017
figureposted on 2017-12-06, 10:57 authored by Andrew SelbyAndrew Selby
Laparoscopic ileocaecal resection versus infiximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. Treatment of patients with ileocaecal Crohn’s disease who have not responded to conventional therapy is commonly scaled up to biological agents, but surgery can also ofer excellent short-term and long-term results. We compared laparoscopic ileocaecal resection with infiximab to assess how they afect health-related quality-of-life.
Dr Robert Brierley, Dr Heather Van Epps
- The Arts, English and Drama
CitationSELBY, A., 2017. The Lancet Gastroenterology & Hepatology Journal Cover November 1st 2017. The Lancet Gastroenterology & Hepatology Journal, 2(11).
- VoR (Version of Record)
Publisher statementThis paper was published in the journal The Lancet Gastroenterology & Hepatology Journal and is available at http://www.thelancet.com/journals/langas/issue/vol2no11/PIIS2468-1253(17)X0010-1.